Back to mobile site

Wells Fargo Downgrades Editas Medicine (EDIT) to Equal Weight

December 11, 2024 4:22 AM EST Send to a Friend
(Updated - December 11, 2024 5:40 AM EST)

Wells Fargo analyst Yanan Zhu downgraded Editas Medicine (NASDAQ: EDIT) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login